JP2010519192A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010519192A5 JP2010519192A5 JP2009549467A JP2009549467A JP2010519192A5 JP 2010519192 A5 JP2010519192 A5 JP 2010519192A5 JP 2009549467 A JP2009549467 A JP 2009549467A JP 2009549467 A JP2009549467 A JP 2009549467A JP 2010519192 A5 JP2010519192 A5 JP 2010519192A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- wnt3a
- therapeutically effective
- fragment
- effective fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0702930.9A GB0702930D0 (en) | 2007-02-15 | 2007-02-15 | Medicaments and methods for inhibition of scarring |
| PCT/GB2008/000500 WO2008099174A1 (en) | 2007-02-15 | 2008-02-14 | Wnt3a for inhibition of scarring |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010519192A JP2010519192A (ja) | 2010-06-03 |
| JP2010519192A5 true JP2010519192A5 (enExample) | 2011-03-31 |
Family
ID=37908674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009549467A Withdrawn JP2010519192A (ja) | 2007-02-15 | 2008-02-14 | 瘢痕の抑制のためのｗｎｔ３ａ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110212897A1 (enExample) |
| EP (1) | EP2117581A1 (enExample) |
| JP (1) | JP2010519192A (enExample) |
| AU (1) | AU2008216004A1 (enExample) |
| CA (1) | CA2678389A1 (enExample) |
| GB (1) | GB0702930D0 (enExample) |
| WO (1) | WO2008099174A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9581723B2 (en) | 2008-04-10 | 2017-02-28 | Schlumberger Technology Corporation | Method for characterizing a geological formation traversed by a borehole |
| US8725477B2 (en) | 2008-04-10 | 2014-05-13 | Schlumberger Technology Corporation | Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics |
| ES2341419B1 (es) * | 2008-08-14 | 2011-05-03 | Hospital Clinic I Provincial De Barcelona | Wnt1 como biomarcador de daño renal. |
| EP2226080A1 (en) * | 2009-03-05 | 2010-09-08 | Universiteit Maastricht | Antagonistic peptides for frizzled-1 and frizzled-2 |
| US8311788B2 (en) | 2009-07-01 | 2012-11-13 | Schlumberger Technology Corporation | Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry |
| KR101285259B1 (ko) * | 2011-08-04 | 2013-07-11 | (주)케어젠 | Ｗｎｔ 계열 유래 펩타이드 및 이의 용도 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1737948A2 (en) * | 2004-04-16 | 2007-01-03 | Hydra Biosciences, Inc. | Methods of promoting cardiac cell proliferation |
| EP1844787A4 (en) * | 2005-01-18 | 2011-10-19 | Univ Kyoto | DRUGS FOR NERVE CELL REGENERATION |
| GB0613031D0 (en) * | 2006-06-30 | 2006-08-09 | Renovo Ltd | Medicaments |
-
2007
- 2007-02-15 GB GBGB0702930.9A patent/GB0702930D0/en not_active Ceased
-
2008
- 2008-02-14 JP JP2009549467A patent/JP2010519192A/ja not_active Withdrawn
- 2008-02-14 AU AU2008216004A patent/AU2008216004A1/en not_active Abandoned
- 2008-02-14 CA CA002678389A patent/CA2678389A1/en not_active Abandoned
- 2008-02-14 US US12/527,182 patent/US20110212897A1/en not_active Abandoned
- 2008-02-14 EP EP08709394A patent/EP2117581A1/en not_active Withdrawn
- 2008-02-14 WO PCT/GB2008/000500 patent/WO2008099174A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522242A5 (enExample) | ||
| JP2010519192A5 (enExample) | ||
| JP2013522303A5 (enExample) | ||
| TN2011000437A1 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| JP2010059183A5 (enExample) | ||
| JP2011528713A5 (enExample) | ||
| JP2015505564A5 (enExample) | ||
| JP2007533687A5 (enExample) | ||
| JP2020524689A5 (enExample) | ||
| WO2010151755A3 (en) | TREATMENT OF INFLAMMATORY DISEASES USING miR-124 | |
| JP2015193630A5 (enExample) | ||
| WO2011074015A3 (en) | Composition of pharmaceutical product to treat sexual dysfunction | |
| JP2014139255A5 (enExample) | ||
| PH12013500559A1 (en) | Combination therapy for treating hcv infection | |
| JP2017105861A5 (enExample) | ||
| JP2013501796A5 (enExample) | ||
| WO2008070010A3 (en) | Hydroxylamine derivatives for the treatment of stroke | |
| CA2541813A1 (en) | Methods for treating acute and overuse sprain and strain using hyaluronic acid | |
| JP2008534503A5 (enExample) | ||
| ATE410163T1 (de) | Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens | |
| JP2009542609A5 (enExample) | ||
| JP2013537901A5 (enExample) | ||
| WO2011022633A3 (en) | Method of threating cancer | |
| UA122336C2 (uk) | Бісамідна похідна дикарбонової кислоти як засіб, що стимулює регенерацію тканин і відновлення знижених функцій тканин | |
| RU2007126638A (ru) | Профилактическое или терапевтическое средство для лечения расстройства сна |